hsa-mir-411: Hsa-mir-411 is a microRNA that is involved in various biological processes and diseases. It has been identified as a potential regulator in the pathogenesis of H. pylori-related gastric cancer (GC) [PMC7410007]. Additionally, hsa-mir-411 has been found to play a role in cancer drug resistance, specifically in drug efflux pathways [PMC9524264]. In the context of good prognosis, hsa-mir-411 is one of the hub microRNAs that are upregulated and may be involved in the negative regulation of transcription [PMC8004706]. Furthermore, hsa-mir-411 is one of the eight miRNAs identified as potential regulators based on miRNA target gene databases [PMC9585797]. In relation to hepatitis C virus (HCV) infection, hsa-mir-411, along with other microRNAs such as hsa-miR-122 and hsa-miR-199a, has been found to influence HCV replication [PMC9493126]. Overall, hsa-mir-411 is a versatile microRNA that has implications in various diseases and biological processes. However, further experimental studies are needed to fully understand its mechanism of action and its role in specific diseases such as H. pylori-related GC.
Sequence features are shown above as colored rectangles. Zoom in and click to view details, or Reset
View annotations in different species by clicking on species names.
Scroll around to explore the entire tree. Click tree nodes to collapse or expand them. Hover over taxon names to display additional information.